Veeral Desai - Mar 14, 2024 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Strategy & Dev. Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Mar 14, 2024
Transactions value $
-$25,627
Form type
4
Date filed
3/18/2024, 08:42 PM
Previous filing
May 11, 2023
Next filing
Apr 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Purchase +12K +3.99% 312K Mar 14, 2024 Direct F1, F2, F3
transaction AGL Common Stock Tax liability -$25.6K -4.9K -1.57% $5.23 307K Mar 14, 2024 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted on April 14, 2021 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 14, 2024.
F2 The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2021 through December 31, 2023. Total attainment achieved was 100%.
F3 Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date.
F4 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale.
F5 Includes restricted stock units.